Radical prostatectomy outcome when performed with PSA above 20 ng/ml.

作者: Oon Sf , Carroll C , Kinsella S , Quinlan Dm , O'Brien Mf

DOI:

关键词:

摘要: Many centres currently do not offer radical prostatectomy (RP) to men with high-risk localised prostate cancer due concerns regarding poor outcome, despite evidence the contrary. We identified 18 undergoing RP serum PSA >20 ng/ml (high-risk by National Comprehensive Cancer Network definition) and minimum follow-up of 12 years (mean 13.5). Mean preoperative was 37.0 (Range 21.1-94.0). Prostatectomy pathology reported extracapsular disease in 16 (88.9%), positive surgical margins 15 (83%) pelvic lymph nodes 5 (27.8%). Overall cancer-specific survival at 10-years 83.3%, 88.2%, 72% 76.5% respectively. With complete 11 (61.1%) are alive, (27.8%) avoided any adjuvant therapy. Complete continence (defined as no involuntary urine leakage use pads) achieved 60%, partial remainder. conclude that surgery for this aggressive variant can result satisfactory outcome.

参考文章(19)
James Mohler, Robert R. Bahnson, Barry Boston, J. Erik Busby, Anthony D'Amico, James A. Eastham, Charles A. Enke, Daniel George, Eric Mark Horwitz, Robert P. Huben, Philip Kantoff, Mark Kawachi, Michael Kuettel, Paul H. Lange, Gary MacVicar, Elizabeth R. Plimack, Julio M. Pow-Sang, Mack Roach, Eric Rohren, Bruce J. Roth, Dennis C. Shrieve, Matthew R. Smith, Sandy Srinivas, Przemyslaw Twardowski, Patrick C. Walsh, Prostate cancer. Clinical practice guidelines in oncology. Journal of The National Comprehensive Cancer Network. ,vol. 8, pp. 162- 200 ,(2010) , 10.6004/JNCCN.2010.0012
Geoffrey T. Gotto, Luis Herran Yunis, Kinjal Vora, James A. Eastham, Peter T. Scardino, Farhang Rabbani, Impact of Prior Prostate Radiation on Complications After Radical Prostatectomy The Journal of Urology. ,vol. 184, pp. 136- 142 ,(2010) , 10.1016/J.JURO.2010.03.031
Tom Budiharto, Christiaan Perneel, Karin Haustermans, Sara Junius, Bertrand Tombal, Pierre Scalliet, Laurette Renard, Evelyne Lerut, Kris Vekemans, Steven Joniau, Hendrik Van Poppel, A multi-institutional analysis comparing adjuvant and salvage radiation therapy for high-risk prostate cancer patients with undetectable PSA after prostatectomy Radiotherapy and Oncology. ,vol. 97, pp. 474- 479 ,(2010) , 10.1016/J.RADONC.2010.07.008
MAXWELL V. MENG, ERIC P. ELKIN, DAVID M. LATINI, JANEEN DuCHANE, PETER R. CARROLL, TREATMENT OF PATIENTS WITH HIGH RISK LOCALIZED PROSTATE CANCER: RESULTS FROM CANCER OF THE PROSTATE STRATEGIC UROLOGICAL RESEARCH ENDEAVOR (CaPSURE) The Journal of Urology. ,vol. 173, pp. 1557- 1561 ,(2005) , 10.1097/01.JU.0000154610.81916.81
Deborah P Lubeck, Gary D Grossfeld, Peter R Carroll, The effect of androgen deprivation therapy on health-related quality of life in men with prostate cancer. Urology. ,vol. 58, pp. 94- 99 ,(2001) , 10.1016/S0090-4295(01)01250-X
Brant A. Inman, Judson D. Davies, Laureano J. Rangel, Eric J. Bergstralh, Eugene D. Kwon, Michael L. Blute, R. Jeffrey Karnes, Bradley C. Leibovich, Long-term outcomes of radical prostatectomy with multimodal adjuvant therapy in men with a preoperative serum prostate-specific antigen level ≥50 ng/mL Cancer. ,vol. 113, pp. 1544- 1551 ,(2008) , 10.1002/CNCR.23767
Ofer Yossepowitch, Scott E. Eggener, Angel M. Serio, Brett S. Carver, Fernando J. Bianco, Peter T. Scardino, James A. Eastham, Secondary Therapy, Metastatic Progression, and Cancer-Specific Mortality in Men with Clinically High-Risk Prostate Cancer Treated with Radical Prostatectomy European Urology. ,vol. 53, pp. 950- 959 ,(2008) , 10.1016/J.EURURO.2007.10.008
Ruth Kirschner-Hermanns, Gerhard Jakse, Quality of life following radical prostatectomy. Critical Reviews in Oncology Hematology. ,vol. 43, pp. 141- 151 ,(2002) , 10.1016/S1040-8428(02)00026-4
Richard Khafagy, David Shackley, Joanne Samuel, Kieran O'Flynn, Chris Betts, Noel Clarke, Complications arising in the final year of life in men dying from advanced prostate cancer. Journal of Palliative Medicine. ,vol. 10, pp. 705- 711 ,(2007) , 10.1089/JPM.2006.0185